Skip to Content

PM1 logo (Pramipexole dihydrochloride 0.125 mg)

Pill imprint PM1 logo has been identified as Pramipexole dihydrochloride 0.125 mg.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pramipexole dihydrochloride
Imprint:
PM1 logo
Strength:
0.125 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3751
Inactive Ingredients:
mannitol
corn starch
silicon dioxide colloidal
povidone k29/32
magnesium stearate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide